Expand VRCA Menu
VRCA MENU

VRCA Stock Posts


VRCA #VerricaPharmaceuticals stock increases 19.2% after hours.

After Hours Gainer

VRCA Verrica Pharmaceuticals4.61-0.08-1.7%

After Hours:5.50+0.89 (+19.2%)

Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2 Trial in Basal Cell Carcinoma (BCC) at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Globe NewswireTue, 7-Oct 4:05 PM
Upcoming Earnings

VRCA Verrica Pharmaceuticals6.80+0.10 (+1.5%)

Verrica Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±10.5% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±23.8%. View Expected Move (Conf Call: Aug 12 4:30 PM)
Upcoming Earnings

VRCA Verrica Pharmaceuticals0.510.00 (+0.8%)

Verrica Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±12.1% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±28.0%. View Expected Move (Conf Call: May 13 4:30 PM)
Upcoming Earnings

VRCA Verrica Pharmaceuticals0.66+0.02 (+3.6%)

Verrica Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±15.1% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±28.1%. View Expected Move (Conf Call: Mar 11 4:30 PM)
Market Data Delayed 15 Minutes